Addition of Anti-Estrogen Therapy to Anti-Her2 Dendritic Cell Vaccination Improves Regional Nodal Immune Response and Pathologic Complete Response Rate in Patients With ERpos/HER2pos Early Breast Cancer
OncoImmunology - United States
doi 10.1080/2162402x.2016.1207032
Full Text
Open PDFAbstract
Available in full text
Date
July 1, 2016
Authors
Publisher
Informa UK Limited